Consistent modest benefit as adjunctive therapy; effect size smaller than for OA.
Relevance to this claim: Ingredient-level evidence for Fish Oil (EPA/DHA)
Relevance to this claim: Ingredient-level evidence for Fish Oil (EPA/DHA)
Relevance to this claim: Clinical improvement in canine osteoarthritis with omega-3 enriched diets.
Outcome: Improved ability to rise and play, reduced lameness
Relevance to this claim: Dose-relevant canine EPA/DHA supplementation data.
Outcome: Increased peak vertical force by force plate
Relevance to this claim: Ingredient-level evidence for Fish Oil (EPA/DHA)








